Literature DB >> 25588908

Laparoscopic reconstruction of an iatrogenic perforation of the neovagina and urinary bladder by a neovaginal dilator in a patient with Mayer-Rokitansky-Küster-Hauser syndrome.

Wael Y Khoder1, Christian G Stief, Maximiliane Burgmann, Alexander Burges.   

Abstract

INTRODUCTION AND HYPOTHESIS: Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) is a rare genital aplasia syndrome. Patients with MRKH regularly dilate their neovagina with vaginal dilatators.
METHODS: A 23-year-old MRKH syndrome patient came to our department complaining of a lost vaginal dilator, which she had inserted 2 days previously. She had no bleeding or abdominal pain, but did have occasional urine loss. She had a history of abdominal exploration for an acute abdomen and the creation of a neovagina at the age of 16. An abdominal CT scan located the dislocated dilator intravesically. After diagnostic laparoscopy, the dilator was removed through the vesico-neovaginal perforation. The vagina was closed and covered by a pedicled peritoneal flap, followed by closure of the urinary bladder. An omental J-flap was then fixed between the vagina and bladder.
RESULTS: The operative time was 185 min, with no significant blood loss, injuries or need for conversion/revision. The indwelling catheter was removed 7 days later after cystography, followed by normal micturition and an adequate bladder capacity. Vaginal dilation and sexual activity was resumed 1 month postoperatively. Follow-up was uneventful.
CONCLUSIONS: Laparoscopic vaginal dilator removal with immediate repair of the perforation of the neovagina and the urinary bladder directly after an acute trauma in a patient with MRKH syndrome may be a management option. It is a feasible, safe and viable operation in the hands of experienced laparoscopists.

Entities:  

Mesh:

Year:  2015        PMID: 25588908     DOI: 10.1007/s00192-014-2609-1

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  19 in total

Review 1.  Genetics of the female reproductive ducts.

Authors:  J L Simpson
Journal:  Am J Med Genet       Date:  1999-12-29

Review 2.  The diagnosis and management of vesicovaginal fistulae.

Authors:  I Romics; Zs Kelemen; Zs Fazakas
Journal:  BJU Int       Date:  2002-05       Impact factor: 5.588

3.  Transvaginal repair and graft interposition for rectovaginal fistula due to a neglected pessary: case report and review of the literature.

Authors:  Paul J Yong; Matthew M Garrey; Roxana Geoffrion
Journal:  Female Pelvic Med Reconstr Surg       Date:  2011-07       Impact factor: 2.091

4.  Surgical approaches to treating vaginal agenesis.

Authors:  L Michala; A Cutner; S M Creighton
Journal:  BJOG       Date:  2007-12       Impact factor: 6.531

5.  Less invasive new vaginoplasty using laparoscopy, atelocollagen sponge, and hand-made mould.

Authors:  Yoshiya Miyahara; Shigeki Yoshida; Tokuro Shirakawa; Natsuko Makihara; Kiyoshi Niiya; Yasuhiko Ebina; Hideto Yamada
Journal:  Kobe J Med Sci       Date:  2013-03-19

6.  Relationship between Mayer-Rokitansky-Küster (MRK) anomaly and hereditary renal adysplasia (HRA).

Authors:  R de C Pavanello; A Eigier; P A Otto
Journal:  Am J Med Genet       Date:  1988-04

7.  Laparoscopic management of recurrent vesicovaginal fistula.

Authors:  J R Miklos; C Sobolewski; V Lucente
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1999

8.  Laparoscopic repair of vesicovaginal fistula.

Authors:  René Sotelo; Mirandolino B Mariano; Alejandro García-Segui; Rinci Dubois; Maximiliano Spaliviero; Wartan Keklikian; John Novoa; Henry Yaime; Antonio Finelli
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

9.  Robotic reconstruction for recurrent supratrigonal vesicovaginal fistulas.

Authors:  Ashok K Hemal; Surendra B Kolla; Pankaj Wadhwa
Journal:  J Urol       Date:  2008-07-17       Impact factor: 7.450

Review 10.  Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.

Authors:  Karine Morcel; Laure Camborieux; Daniel Guerrier
Journal:  Orphanet J Rare Dis       Date:  2007-03-14       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.